Brittney Shulman Zimmerman and Francisco J. Esteva
Oct 25, 2024, 19:14
Next-Generation HER2-Targeted ADC’s in Breast Cancer – Cancers MDPI
Cancers MDPI shared a post on LinkedIn:
”Check out the Editor’s Choice Article ‘Next-Generation HER2-Targeted Antibody–Drug Conjugates in Breast Cancer‘ by Brittney Shulman Zimmerman and Francisco J. Esteva.
I believe that this article would be worth highlighting as it addresses one of the newest and most exciting areas of cancer therapeutics.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:54
Feb 21, 2025, 09:45
Feb 21, 2025, 09:35
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20